Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase I/II trials suggest efficacy of Neuvax vaccine in prevention of breast cancer recurrence

Oct. 13, 2010

Pfizer introduces new candidates for inhalation therapy of COPD

Oct. 13, 2010

First-in-human data disclosed on NIBR-6465

Oct. 13, 2010

Snapshots: Recent data on the antibacterial activity of CXA-101

Oct. 13, 2010

Pfizer's antibacterial MC-1 shows promising preclinical activity

Oct. 13, 2010

DC-based TaReNef AIDS vaccine is safe and immunogenic in phase I/II trial

Oct. 13, 2010

AGI-101 improves postsurgery survival in high-risk melanoma

Oct. 11, 2010

Tasocitinib meets primary endpoint in phase II psoriasis trial

Oct. 11, 2010

PP-9706642 shows promise as a prophylactic/therapeutic agent for HSV-2 infection

Oct. 11, 2010

Debio-0719 suppresses metastasis in mouse models of breast cancer

Oct. 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...